M. DAVID MACFARLANE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2018-12-20 M. David MacFarlane(4) Fees Earned or Paid in Cash ($) 60,000 ... The aggregate number of option awards held at December 19, 2018 was 57,277.

Data sourced from SEC filings. Last updated: 2025-10-11